HMC
Honda Motor Co., Ltd.
HMC has a slight edge over TSLA overall, supported by stronger valuation and lower modeled downside.
TSLA
Tesla, Inc.
TSLA offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
HMC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Stable | |
| Strong |
HMC's revenue and balance sheet are currently healthy, and its cash flow is stable, but its profitability is under pressure.
TSLA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Strong |
TSLA's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
HMC PE Valuation
HMC has no meaningful PE right now: it lost money over the past year.
TSLA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 60x | $54.70 | -86% |
| Fair | 174x | $158 | -60% |
| Forward | 196x | $397 | — |
| Expensive | 415x | $378 | -4.9% |
| Current | 437x | $397 | — |
Historical ranges are pointers, not guarantees.
TSLA's PE is in its expensive range at 437x. If earnings grow as analysts expect, today's price would be 196x next year's earnings, in its fair range.
HMC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
HMC has the edge over TSLA on the outlook, with more favorable profitability expectations.
TSLA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for TSLA, with profitability holding steady. However, they disagree widely on these estimates.
HMC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.81 | -131% |
| Q1 2026 | -$2.11 | -164% |
| Q4 2025 | $2.25 | -45% |
| Q3 2025 | $2.75 | -28% |
| Q2 2025 | $2.63 | -40% |
| Q1 2025 | $3.29 | -22% |
| Q4 2024 | $4.08 | +14% |
| Q3 2024 | $3.83 | +9.4% |
HMC has swung to a loss: it lost $0.81 per share over the past year, after a profit the year before.
TSLA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.03 | +123% |
| Q3 2026 | $0.91 | -39% |
| Q2 2026 | $1.08 | -38% |
| Q1 2026 | $1.09 | -40% |
| Q4 2025 | $1.08 | -47% |
| Q3 2025 | $1.50 | -59% |
| Q2 2025 | $1.73 | -51% |
| Q1 2025 | $1.82 | -53% |
| Q4 2024 | $2.04 | -53% |
TSLA has the edge over HMC on earnings quality, reporting a profit while its opponent remains loss making.
HMC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $38B | +14% |
| Q1 2026 | $36.5B | +8.6% |
| Q4 2025 | $33.5B | -3.4% |
| Q3 2025 | $33.2B | -1.9% |
| Q2 2025 | $33.5B | -1.2% |
| Q1 2025 | $33.6B | -1.3% |
| Q4 2024 | $34.7B | +2.6% |
| Q3 2024 | $33.8B | +8.2% |
HMC's revenue is growing: $38B last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 8.8% | +4.2 points |
| Q1 2026 | -17% | -19 points |
| Q4 2025 | 2.9% | -4.3 points |
| Q3 2025 | 3.7% | -15 points |
| Q2 2025 | 4.6% | -4.4 points |
| Q1 2025 | 1.4% | -4.3 points |
| Q4 2024 | 7.2% | +0.1 points |
| Q3 2024 | 19% | +13 points |
HMC has the edge over TSLA on profitability, with a higher operating margin.
TSLA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $28B | -0.2% |
| Q2 2026 | $28.2B | +26% |
| Q1 2026 | $22.4B | +16% |
| Q4 2025 | $24.9B | -3.1% |
| Q3 2025 | $28.1B | +12% |
| Q2 2025 | $22.5B | -12% |
| Q1 2025 | $19.3B | -9.2% |
| Q4 2024 | $25.7B | +2.1% |
TSLA has the edge over HMC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.6% | -3.2 points |
| Q2 2026 | 1.4% | -2.7 points |
| Q1 2026 | 4.2% | +2.1 points |
| Q4 2025 | 5.7% | -0.5 points |
| Q3 2025 | 5.8% | -5 points |
| Q2 2025 | 4.1% | -2.2 points |
| Q1 2025 | 2.1% | -3.4 points |
| Q4 2024 | 6.2% | -2 points |
TSLA's operating margin was 2.6% last quarter, down 3.2 points from the same quarter a year ago, near the bottom of its range since 2019.
HMC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$2.2B | -$1.4B |
| Q1 2026 | $870.1M | +$1.8B |
| Q4 2025 | $612.2M | +$1.3B |
| Q3 2025 | $726.9M | +$772.3M |
| Q2 2025 | -$719.2M | $0 |
| Q1 2025 | -$942.2M | $0 |
| Q4 2024 | -$683.5M | $0 |
| Q3 2024 | -$45.5M | $0 |
HMC's free cash flow has turned positive after two years mostly in the red: $45M over the past year.
TSLA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.5B | -62% |
| Q2 2026 | -$1.1B | -848% |
| Q1 2026 | $1.4B | +117% |
| Q4 2025 | $1.4B | -30% |
| Q3 2025 | $4B | +46% |
| Q2 2025 | $146M | -89% |
| Q1 2025 | $664M | +$3.2B |
| Q4 2024 | $2B | -1.6% |
TSLA still generates free cash flow, though less than at its 2025 peak: $3.3B over the past year.
HMC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.7% | +62.8M shares |
| 1 year | 0% | -42.7K shares |
| 3 years | -15% | -257M shares |
| 5 years | -19% | -326M shares |
| Available history | -20% | -359M shares |
HMC has the edge over TSLA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | $576,658 |
| Q4 2025 | — |
| Q3 2025 | $1.9B |
| Q2 2025 | $2.3B |
| Q1 2025 | $2.7B |
| Q4 2024 | $423.3M |
| Q3 2024 | $1.3B |
HMC spent $1.9B buying back its own shares over the past year, down 71% from the year before.
TSLA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1M shares |
| 1 year | +0.4% | +15M shares |
| 3 years | +1.4% | +48M shares |
| 5 years | +5.1% | +172M shares |
| Available history | +33% | +886M shares |
TSLA has 3.5B diluted shares, about the same as a year ago.
HMC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -3.9x | Net Cash |
| Q1 2026 | 8.6x | High |
| Q4 2025 | 4.9x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | 2.8x | Moderate |
| Q3 2024 | 2.5x | Moderate |
HMC has the edge over TSLA on leverage, with a lower net debt burden relative to earnings.
TSLA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -1.1x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
TSLA has more cash than debt.
HMC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.4 | Neutral |
| Stochastic | 71.9 | Neutral |
HMC's weekly RSI is 58 (neutral) and its Stochastic is 72 (neutral).
TSLA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.3 | Neutral |
| Stochastic | 72.6 | Neutral |
TSLA's weekly RSI is 54 (neutral) and its Stochastic is 73 (neutral).
HMC PE vs Consumer Cyclical Sector
| Metric | HMC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
HMC has no meaningful PE right now: it lost money over the past year.
TSLA PE vs Consumer Cyclical Sector
| Metric | TSLA | Sector median | Relative |
|---|---|---|---|
| PE | 437x | 18x | 2,324% above |
| PE % | 84 | 47 | 37 pts above |
TSLA is trading at 437x earnings, a 2324% premium to the Consumer Cyclical sector's median of 18x.
HMC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $33.6 | 0.2% below |
| 20 week MA | $31.9 | 5.3% above |
| 50 week MA | $29.4 | 14% above |
| 100 week MA | $29.7 | 13% above |
| 200 week MA | $30.3 | 11% above |
HMC has slipped below its 8-week average, but it's still above the other four, and 11% above its 200-week average.
TSLA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $376.0 | 5.7% above |
| 20 week MA | $364.0 | 9.2% above |
| 50 week MA | $393.6 | 1% above |
| 100 week MA | $372.1 | 6.8% above |
| 200 week MA | $296.9 | 34% above |
TSLA has the edge over HMC on trend strength, trading above more of its moving averages.
HMC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.6 | $28.6 | -0.1% |
| 2021 | $28.6 | $28.1 | -1.7% |
| 2022 | $28.1 | $23.1 | -18% |
| 2023 | $23.1 | $30.9 | +34% |
| 2024 | $30.9 | $28.8 | -7% |
| 2025 | $28.8 | $29.8 | +3.6% |
| 2026 YTD | $29.8 | $33.5 | +13% |
HMC has the edge over TSLA on returns for 2026, with the stronger performance.
TSLA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.7 | $220.6 | +669% |
| 2021 | $220.6 | $355.7 | +61% |
| 2022 | $355.7 | $123.2 | -65% |
| 2023 | $123.2 | $248.5 | +102% |
| 2024 | $248.5 | $431.7 | +74% |
| 2025 | $431.7 | $475.2 | +10% |
| 2026 YTD | $475.2 | $397.5 | -16% |
TSLA's yearly returns have swung widely, from +669% in 2020 to −65% in 2022. It's down 16% so far in 2026.